In a filing, Nuvation Bio Inc revealed its Director Cui Xiangmin acquired Company’s shares for reported $0.83 million on Jun 25 ’24. In the deal valued at $2.97 per share,277,895 shares were bought. As a result of this transaction, Cui Xiangmin now holds 2,453,131 shares worth roughly $5.91 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Cui Xiangmin bought 336,874 shares, generating $1,003,885 in total proceeds. Upon buying the shares at $2.98, the Director now owns 2,175,236 shares.
Before that, Cui Xiangmin bought 87,715 shares. Nuvation Bio Inc shares valued at $262,268 were divested by the Director at a price of $2.99 per share. As a result of the transaction, Cui Xiangmin now holds 1,762,951 shares, worth roughly $4.25 million.
Jefferies upgraded its Nuvation Bio Inc [NUVB] rating to a Buy from a a Hold in a research note published on March 27, 2024; the price target was increased to $10 from $1.40. A number of analysts have revised their coverage, including BTIG Research’s analysts, who increased its forecast for the stock in late March from “a Neutral” to “a Buy”. Jefferies also remained covering NUVB and has decreased its forecast on January 06, 2023 with a “Hold” recommendation from previously “Buy” rating. BTIG Research revised its rating on August 02, 2022. It rated NUVB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of NUVB
On Friday, Nuvation Bio Inc [NYSE:NUVB] saw its stock jump 2.99% to $2.41. Over the last five days, the stock has gained 0.84%. Nuvation Bio Inc shares have risen nearly 59.60% since the year began. Nevertheless, the stocks have risen 94.35% over the past one year. While a 52-week high of $4.16 was reached on 03/28/24, a 52-week low of $0.95 was recorded on 01/18/24. SMA at 50 days reached $2.92, while 200 days put it at $2.63.
Levels Of Support And Resistance For NUVB Stock
The 24-hour chart illustrates a support level at 2.35, which if violated will result in even more drops to 2.29. On the upside, there is a resistance level at 2.44. A further resistance level may holdings at 2.47. The Relative Strength Index (RSI) on the 14-day chart is 38.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.55%. Stochastics %K at 17.49% indicates the stock is a buying.
How much short interest is there in Nuvation Bio Inc?
A steep rise in short interest was recorded in Nuvation Bio Inc stocks on 2024-09-13, growing by 3.73 million shares to a total of 20.23 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 16.5 million shares. There was a rise of 18.44%, which implies that there is a positive sentiment for the stock.
